Most visited
A New Era in Weight Loss: Endura Weight Loss Solutions
People living with obesity face many challenges throughout their weight loss journey - from managing diet and exercise to coping with the physical, mental, and emotional ups and downs. It’s a journey that requires real endurance.
At Boston Scientific, we understand these challenges. That’s why we offer a new approach to endobariatrics: Endura Weight Loss Solutions - a suite of effective, minimally invasive endoscopic bariatric procedures designed to support sustainable weight loss.
The portfolio includes Endoscopic Sleeve Gastroplasty (ESG), Transoral Outlet Reduction (TORe), and Intragastric Balloons (IGBs), each tailored to meet different patient needs.
Weight Loss Options
Endoscopic Sleeve Gastroplasty (ESG)
Endorsed by the IFSO Bariatric Endoscopy Committee1 and performed using the OverStitch NXT™ Endoscopic Suturing System, ESG is a minimally invasive procedure designed to support gradual and lasting weight loss when combined with lifestyle changes.
Transoral Outlet Reduction (TORe)
Performed using the OverStitch NXT™ Endoscopic Suturing System, TORe is a minimally invasive procedure intended for patients who have regained weight after Roux-en-Y gastric bypass.
Intragastric Balloons (IGBs)
IGBs are a temporary, minimally invasive option that helps patients adapt to smaller portion sizes and develop healthier eating habits.
Key Resources
Expert Insights
Dr. Bansi and Dr. Lubbe discuss the evolving role of Endobariatrics in obesity treatment, highlighting multidisciplinary care and the adoption of ESG.
Resources for Patients
Discover comprehensive resources tailored for patients across the UK, Italy, Germany, Spain, and France.
Patient Brochures
Alternative bariatric procedures
- Laparoscopic sleeve gastrectomy (LSG), also referred to as vertical sleeve gastrectomy, is a restrictive bariatric procedure predominantly performed via laparoscopy. During LSG, approximately 75-85% of the stomach is resected along the greater curvature. This procedure induces significant neurohormonal and bile signaling modifications, contributing to its metabolic efficacy.2
- Roux-en-Y gastric bypass (RYGB) involves the exclusion of a portion of the stomach and proximal intestine, with the distal intestine reconfigured into a Y-configuration. This allows for the passage of ingested food from the upper gastric pouch through the Roux limb, facilitating both weight loss and metabolic benefits, independent of weight reduction.2
References
1. IFSO Bariatric Endoscopy Committee Evidence‑Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management. 2024.
2. IFSO-WGO GUIDELINES ON OBESITY CONTENTS 2022.